• Nanoligent raises €1M in Series Seed financing
PRESS RELEASE Barcelona, Spain – Milan, Italy – Basel, Switzerland, February 3rd, 2022 – Nanoligent SL, a biotech company specialized in the development of nanotechnology-based cancer treatments, today announces the completion of the first closing of a Seed financing round of €1M. The round has been led by members of Italian Angels for Growth, the …
• Nanoligent raises €1M in Series Seed financing Read More »